DOI QR코드

DOI QR Code

Corn silk extract improves benign prostatic hyperplasia in experimental rat model

  • Kim, So Ra (Department of Food Science and Nutrition, Dankook University) ;
  • Ha, Ae Wha (Department of Food Science and Nutrition, Natural Nutraceuticals Industrization Research Center, DanKook University) ;
  • Choi, Hyun Ji (Department of Food Science and Nutrition, Dankook University) ;
  • Kim, Sun Lim (Crop Foundation Division National Institute of Crop Science, RDA) ;
  • Kang, Hyeon Jung (Crop Post-harvest Technology Division, National Institute of Crop Science, RDA) ;
  • Kim, Myung Hwan (Department of Food Engineering, Dankook University) ;
  • Kim, Woo Kyoung (Department of Food Science and Nutrition, Dankook University)
  • Received : 2017.05.02
  • Accepted : 2017.06.23
  • Published : 2017.10.02

Abstract

BACKGROUND/OBJECTIVES: This study was conducted to investigate the effect of a corn silk extract on improving benign prostatic hyperplasia (BPH). MATERIALS/METHODS: The experimental animals, 6-week-old male Wistar rats, were divided into sham-operated control (Sham) and experimental groups. The experimental group, which underwent orchiectomy and received subcutaneous injection of 10 mg/kg of testosterone propionate to induce BPH, was divided into a Testo Only group that received only testosterone, a Testo+Fina group that received testosterone and 5 mg/kg finasteride, a Testo+CSE10 group that received testosterone and 10 mg/kg of corn silk extract, and a Testo+CSE100 group that received testosterone and 100 mg/kg of corn silk extract. Prostate weight and concentrations of dihydrotestosterone (DHT), $5{\alpha}$- reductase $2(5{\alpha}-R2)$, and prostate specific antigen (PSA) in serum or prostate tissue were determined. The mRNA expressions of $(5{\alpha}-R2)$ and proliferating cell nuclear antigen (PCNA) in prostate tissue were also measured. RESULTS: Compared to the Sham group, prostate weight was significantly higher in the Testo Only group and decreased significantly in the Testo+Fina, Testo+CSE10, and Testo+CSE100 groups (P < 0.05), results that were consistent with those for serum DHT concentrations. The concentrations of $(5{\alpha}-R2)$ in serum and prostate as well as the mRNA expression of $(5{\alpha}-R2)$ in prostate were significantly lower in the Testo+Fina, Testo+CSE10, and Testo+CSE100 groups than that in the Testo Only group (P < 0.05). Similarly, the concentrations of PSA in serum and prostate were significantly lower in the Testo+Fina, Testo+CSE10, and Testo+CSE100 groups (P < 0.05) than in the Testo Only group. The mRNA expression of PCNA in prostate dose-independently decreased in the Testo+CSE-treated groups (P < 0.05). CONCLUSIONS: BPH was induced through injection of testosterone, and corn silk extract treatment improved BPH symptoms by inhibiting the mRNA expression of $(5{\alpha}-R2)$ and decreasing the amount of $(5{\alpha}-R2)$, DHT, and PSA in serum and prostate tissue.

Keywords

References

  1. Hasanudin K, Hashim P, Mustafa S. Corn silk (Stigma maydis) in healthcare: a phytochemical and pharmacological review. Molecules 2012;17:9697-715. https://doi.org/10.3390/molecules17089697
  2. Grases F, March JG, Ramis M, Costa-Bauza A. The influence of Zea mays on urinary risk factors for kidney stones in rats. Phytother Res 1993;7:146-9. https://doi.org/10.1002/ptr.2650070210
  3. Min OJ, Sharma BR, Park CM, Rhyu DY. Effect of myadis stigma water extract on adipogenesis and blood glucose in 3T3-L1 adipocytes and db/db mice. Korean J Pharmacogn 2011;42:201-8.
  4. Kim SL, Kim MJ, Lee YY, Jung GH, Son BY, Lee JS, Kwon YU, Park YI. Isolation and identification of flavonoids from corn silk. Korean J Crop Sci 2014;59:435-44. https://doi.org/10.7740/kjcs.2014.59.4.435
  5. Byrne PF, McMullen MD, Snook ME, Musket TA, Theuri JM, Widstrom NW, Wiseman BR, Coe EH. Quantitative trait loci and metabolic pathways: genetic control of the concentration of maysin, a corn earworm resistance factor, in maize silks. Proc Natl Acad Sci U S A 1996;93:8820-5. https://doi.org/10.1073/pnas.93.17.8820
  6. Lee YJ, Lee JW, Park J, Seo SI, Chung JI, Yoo TK, Son H. Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea. Investig Clin Urol 2016;57:424-30. https://doi.org/10.4111/icu.2016.57.6.424
  7. Unnikrishnan R, Almassi N, Fareed K. Benign prostatic hyperplasia: evaluation and medical management in primary care. Cleve Clin J Med 2017;84:53-64. https://doi.org/10.3949/ccjm.84a.16008
  8. Cho SH, Han YH, Kim YS. Effects of bee venom herbal acupuncture on experimental rat model of benign prostatic hyperplasia. J Korean Orient Intern Med 2010;31:166-76.
  9. Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res 2008;20 Suppl 3:S11-8.
  10. Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. World J Urol 2002;19:413-25. https://doi.org/10.1007/s00345-002-0248-5
  11. Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review. J Clin Aesthet Dermatol 2016;9:56-62.
  12. Guo M, Heran B, Flannigan R, Kezouh A, Etminan M. Persistent sexual dysfunction with finasteride 1 mg taken for hair loss. Pharmacotherapy 2016;36:1180-4. https://doi.org/10.1002/phar.1837
  13. Kang HS, Kim GY, Jung I, Oh SD, Kim CH, Shim BS, Park KH, Oh SJ. The effect of the compound of tomato extract to the prostatic cancer cell and the prostate of the rat model of benign prostatic hyperplasia. Korean J Pharmacogn 2007;38:197-203.
  14. Mobley D, Feibus A, Baum N. Benign prostatic hyperplasia and urinary symptoms: evaluation and treatment. Postgrad Med 2015;127:301-7. https://doi.org/10.1080/00325481.2015.1018799
  15. Lee SJ, Choi HR, Lee JH, Kwon JW, Lee HK, Jeong JT, Lee TB. Effects of unripe black raspberry extracts on prostate cancer cell line and rat model of benign prostatic hyperplasia. J Korean Soc Food Sci Nutr 2014;43:507-15. https://doi.org/10.3746/jkfn.2014.43.4.507
  16. Moon JM, Seok GH, Cho SI. Antiproliferative effect of schisandrae fructus extract on PC-3 human prostate cancer cells. Korean J Herbol 2012;27:17-23.
  17. Singh NK, Sahu AN, Singh SK. Free radical scavenging and hepatoprotective activities of standardized methanolic Extract of Maydis Stigma. Pharmacologyonline 2009;2:440-9.
  18. Liu J, Wang C, Wang Z, Zhang C, Lu S, Liu J. The antioxidant and free-radical scavenging activities of extract and fractions from corn silk (Zea mays L.) and related flavone glycosides. Food Chem 2011;126:261-9. https://doi.org/10.1016/j.foodchem.2010.11.014
  19. Al-Ali M, Wahbi S, Twaij H, Al-Badr A. Tribulus terrestris: preliminary study of its diuretic and contractile effects and comparison with Zea mays. J Ethnopharmacol 2003;85:257-60. https://doi.org/10.1016/S0378-8741(03)00014-X
  20. Lee EY, Kim SL, Kang HJ, Kim MH, Ha AW, Kim WK. High maysin corn silk extract reduces body weight and fat deposition in C57BL/6J mice fed high-fat diets. Nutr Res Pract 2016;10:575-82. https://doi.org/10.4162/nrp.2016.10.6.575
  21. Lee J, Kim SL, Lee S, Chung MJ, Park YI. Immunostimulating activity of maysin isolated from corn silk in murine RAW 264.7 macrophages. BMB Rep 2014;47:382-7. https://doi.org/10.5483/BMBRep.2014.47.7.191
  22. Lee J, Lee S, Kim SL, Choi JW, Seo JY, Choi DJ, Park YI. Corn silk maysin induces apoptotic cell death in PC-3 prostate cancer cells via mitochondria-dependent pathway. Life Sci 2014;119:47-55. https://doi.org/10.1016/j.lfs.2014.10.012
  23. Lee DH, Lee JS, Kim YS. The effects of lygodium japonicum on experimental rat model of benign prostatic hyperplasia. J Korean Orient Intern Med 2010;31:457-66.
  24. Park DJ, Kang SH, Cho YH. The antihyperplastic effect of oral catechin ingestion in a rat model of benign prostatic hyperplasia. Korean J Urol 2006;47:1289-93. https://doi.org/10.4111/kju.2006.47.12.1289
  25. Wu X, Gu Y, Li L. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats. Toxicol Lett 2017;265:9-16. https://doi.org/10.1016/j.toxlet.2016.11.011
  26. Cha JH, Kim SR, Kang HJ, Kim MH, Ha AW, Kim WK. Corn silk extract improves cholesterol metabolism in C57BL/6J mouse fed high-fat diets. Nutr Res Pract 2016;10:501-6. https://doi.org/10.4162/nrp.2016.10.5.501
  27. Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 1997;127:838S-841S. https://doi.org/10.1093/jn/127.5.838S
  28. Park JS, Moon JH, Huh JS, Kong MH, Kim HJ. Comparison of correlation between prostate volume and obesity indices. Korean J Obes 2015;24:95-100. https://doi.org/10.7570/kjo.2015.24.2.95
  29. Bruchovsky N, Lesser B, Van Doorn E, Craven S. Hormonal effects on cell proliferation in rat prostate. Vitam Horm 1975;33:61-102.
  30. Afriyie DK, Asare GA, Bugyei K, Adjei S, Lin JM, Peng J, Hong ZF. Treatment of benign prostatic hyperplasia with Croton membranaceus in an experimental animal model. J Ethnopharmacol 2014;157:90-8. https://doi.org/10.1016/j.jep.2014.09.007
  31. Kim CW, Lee KH. Effects of paljeong-san pharmacopuncture on experimental rat model of benign prostatic hyperplasia. J Korean Acupunct Moxibustion Soc 2014;31:95-103.
  32. Jaskulski D, Gatti C, Travali S, Calabretta B, Baserga R. Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors. J Biol Chem 1988;263:10175-9.
  33. Zhong W, Peng J, He H, Wu D, Han Z, Bi X, Dai Q. Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia. Clin Invest Med 2008;31:E8-15.
  34. Zhong X, Lin J, Zhou J, Xu W, Hong Z. Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo. Mol Med Rep 2015;12:1699-708. https://doi.org/10.3892/mmr.2015.3566

Cited by

  1. Rapid discovery and global characterization of multiple components in corn silk using a multivariate data processing approach based on UHPLC coupled with electrospray ionization/quadrupole time-of-flight mass spectrometry vol.41, pp.21, 2018, https://doi.org/10.1002/jssc.201800605
  2. Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats pp.07673981, 2018, https://doi.org/10.1111/fcp.12384
  3. Corn silk decoction for blood lipid in patients with angina pectoris: A systematic review and meta‐analysis vol.33, pp.11, 2017, https://doi.org/10.1002/ptr.6474